Expression of mir-148/152 family as potential biomarkers in non-small-cell lung cancer

Medical Science Monitor

Volumn 21, Issue , 2015, Pages 1155-1161

  Li, Li ^a   Chen, Ye Ye ^a   Li, Shan Qing ^a   Huang, Cheng ^a   Qin, Ying Zhi ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Biological Markers; Carcinoma; MicroRNAs; Non Small Cell Lung; Serum

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; MICRORNA; MICRORNA 148A; MICRORNA 148B; MICRORNA 152; UNCLASSIFIED DRUG; MIRN148 MICRORNA, HUMAN; MIRN152 MICRORNA, HUMAN; TRANSCRIPTOME; TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; LUNG GRANULOMA; LUNG PSEUDOTUMOR; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; PROTEIN EXPRESSION; PULMONARY SCLEROSING HEMANGIOMA; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TUBERCULOSIS; TUMOR VOLUME; BLOOD; CARCINOMA, NON-SMALL-CELL LUNG; CASE CONTROL STUDY; GENETICS; LUNG DISEASE; LUNG NEOPLASMS; MIDDLE AGED; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; DOWN-REGULATION; FEMALE; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; TRANSCRIPTOME;

EID: 84928480247     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.892940     Document Type: Article

References (29)

1. Murray N: Reality check for pemetrexed and maintenance therapy in advanced non-small-cell lung cancer. J Clin Oncol, 2014; 32: 482-83
2. Ponn RB, Lo Cicero J III, Daly BD: Surgical treatment of non-small cell lung cancer. General Thoracic Surgery, 2005; 6: 1548-87
3. Rutnam ZJ, Yang BB: The involvement of microRNAs in malignant transformation. Histol Histopathol, 2012; 27: 1263-70
4. Winter J, Jung S, Keller S et al: Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol, 2009; 11: 228-34
5. Skrzypski M, Dziadziuszko R, Jassem J: MicroRNA in lung cancer diagnostics and treatment. Mutat Res, 2011; 717: 25-31
6. Mitchell PS, Parkin RK, Kroh EM et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA, 2008; 105: 10513-18
7. Fang Y, Yao Q, Chen Z et al: Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine. Med Sci Monit, 2013; 19: 916-26
8. Chen Y, Song YX, Wang ZN: The microRNA-148/152 family: multi-faceted players. Mol Cancer, 2013; 12: 43
9. Li J, Song Y, Wang Y et al: MicroRNA-148a suppresses epithelial-to-mesenhymal transition by targeting ROCK1 in non-small cell lung cancer cells. Mol Cell Biochem, 2013; 380: 277-82
10. Liu GL, Liu X, Lv XB et al: MiR-148b functions as a tumor suppressor in non-small cell lung cancer by targeting carcinoembryonic antigen (CEA). Int J Clin Exp Med, 2014; 7: 1990-99
11. Cheng Z, Ma R, Tan W, Zhang L: MiR-152 suppresses the proliferation and invasion of NSCLC cells by inhibiting FGF2. Exp Mol Med, 2014; 46: e112
12. Su Y, Wang Y, Zhou H et al: MicroRNA-152 targets ADAM17 to suppress NSCLC progression. FEBS Lett, 2014; 588: 1983-88
13. Bekci TT, Senol T, Maden E: The efficacy of serum carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 15-3 (CA15-3), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determining the malignancy of solitary pulmonary nodules. J Int Med Res, 2009; 37: 438-45
14. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 2004; 116: 281-97
15. Di Leva G, Garofalo M, Croce CM: MicroRNAs in cancer. Annu Rev Pathol, 2014; 9: 287-314
16. Zhang H, Qi F, Cao Y et al: Down-regulated microRNA-101 in bladder transitional cell carcinoma is associated with poor prognosis. Med Sci Monit, 2014; 20: 812-17
17. Wang Z, Cai Q, Jiang Z et al: Prognostic role of MicroRNA-21 in gastric cancer: a meta-analysis. Med Sci Monit, 2014; 20: 1668-74
18. Liu Y, Zhao J, Zhang PY et al: MicroRNA-10b targets E-cadherin and modulates breast cancer metastasis. Med Sci Monit, 2012; 18(9): BR299-308
19. Wang J, Tian X, Han R et al: Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer. Oncogene, 2014; 33: 1181-89
20. Cai J, Wu J, Zhang H et al: miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation. Cancer Res, 2013; 73: 756-66
21. Cai J, Fang L, Huang Y et al: miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer. Cancer Res, 2013; 73: 5402-15
22. Hatley ME, Patrick DM, Garcia MR et al: Modulation of K-Rasdependent lung tumorigenesis by MicroRNA-21. Cancer Cell, 2010; 18: 282-93
23. Zandberga E, Kozirovskis V, Abols A et al: Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer. Genes Chromosomes Cancer, 2013; 52: 356-69
24. Fanini F, Vannini I, Amadori D, Fabbri M: Clinical implications of microRNAs in lung cancer. Semin Oncol, 2011; 38: 776-80
25. Rani S, Gately K, Crown J et al: Global analysis of serum microRNAs as potential biomarkers for lung adenocarcinoma. Cancer Biol Ther, 2013; 14: 1104-12
26. Wang Y, Gu J, Roth JA et al: Pathway-based serum microRNA profiling and survival in patients with advanced stage non-small cell lung cancer. Cancer Res, 2013; 73: 4801-9
27. Markou A, Sourvinou I, Vorkas PA et al: Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Lung Cancer, 2013; 81: 388-96
28. Zen K, Zhang CY: Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev, 2012; 32: 326-48
29. Sanfiorenzo C, Ilie MI, Belaid A et al: Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. PLoS One, 2013; 8: e54596